pharma-software
(2)
Pep Gubau Bet on AI Before Pharma Wanted to Hear About It
A two-week internship taught him what he did not want. Four decades, two exits and one stubborn bet later, Pep Gubau is still trying to make industrial data useful where every decision needs a paper trail.
Mike Stapleton
Mike Stapleton is the Chief Business Officer of QbDVision, the Austin-based software company building a Digital CMC platform for pharma and biotech. He spent three decades moving between the lab bench, the boardroom, and the consulting deck - senior scientist at BP, COO at Accelrys, leader at Life Technologies, PerkinElmer, Merck, Microsoft, and Accenture - before joining QbDVision's board and then stepping in to run its commercial strategy. His argument is contrarian for a software executive: the bottleneck in drug development is not the platform, it is the people willing to standardize how an industry handles its data.